UPDATE : Monday, October 14, 2019
상단여백
‘I will help make Korea original holder of anticancer drugs’ by So Jae-hyeon 2018-10-29 14:43
‘Bio Solution’s value to rise on arthritis cell therapy’ by Nam Doo-hyun 2018-10-25 16:30
Samsung BioLogics posts ₩101.1 billion in Q3 sales by Lee Han-soo 2018-10-25 11:02
CancerRop advances into Malaysian gene market by Lee Han-soo 2018-10-24 17:49
Celltrion releases clinical trial results for Remsima SC in EU and US by Lee Han-soo 2018-10-24 16:47
라인
Will synthetic biology be vital in smart therapeutics? by Nam Doo-hyun 2018-10-24 16:40
Biotech shares tank amid nosediving of Seoul stocks by Nam Doo-hyun 2018-10-24 11:35
‘Antibody drug developer AbClon noteworthy’ by Nam Doo-hyun 2018-10-22 14:49
L&C BIO sets offering price at ₩24,000 for KOSDAQ debut by So Jae-hyeon 2018-10-22 14:12
'Superbug' fears bring antibiotics developers under spotlight by Nam Doo-hyun 2018-10-22 11:53
라인
Celltrion, Samsung BioLogics named Fortune’s ‘Future 50’ by Lee Han-soo 2018-10-19 16:34
CancerRop launches unit to develop cell therapies by Lee Han-soo 2018-10-18 15:25
Biogen, Samsung Bioepis announce European launch of Imraldi by Lee Han-soo 2018-10-17 17:28
Bio stocks listed under ‘tech exception policy’ perform better by Nam Doo-hyun 2018-10-15 12:27
Merck to supply Samsung’s biosimilar to US Veterans Affairs Dept. by Lee Han-soo 2018-10-11 16:31
라인
US drug advisory recommends Celltrion’s Rituxan biosimilar for approval by Lee Han-soo 2018-10-11 12:10
‘Korea publishes many biotech papers but rarely links them to biz’ by Nam Doo-hyun 2018-10-10 16:35
GC opens new cell research center by Lee Han-soo 2018-10-10 11:45
More biotech stocks come in top 20 on KOSDAQ by Nam Doo-hyun 2018-10-10 11:20
Newly listed biotech firms perform poorly on KOSDAQ by Nam Doo-hyun 2018-10-04 13:09
여백
여백
여백
Back to Top